What is the address of Dr. Ann De Cleene Anesthesist?

The registered office of Dr. Ann De Cleene Anesthesist is located at Pruimenbosstraat 13, 9840 Nazareth-De Pinte.

Is Dr. Ann De Cleene Anesthesist still active?

Yes. According to the CBE (18 September 2026) Dr. Ann De Cleene Anesthesist is active, legal situation “Normale toestand”, started on 2 May 2011.

Is Dr. Ann De Cleene Anesthesist registered on Peppol?

Yes, Dr. Ann De Cleene Anesthesist is registered on the Peppol network with ID 0208:0836001725.

What is the enterprise number of Dr. Ann De Cleene Anesthesist?

The enterprise number of Dr. Ann De Cleene Anesthesist is BE0836001725.

When was Dr. Ann De Cleene Anesthesist founded?

Dr. Ann De Cleene Anesthesist was founded on 2 May 2011.

Who are the directors of Dr. Ann De Cleene Anesthesist?

According to the 2025 annual accounts, the directors of Dr. Ann De Cleene Anesthesist are: Ann De Cleene.

Is Dr. Ann De Cleene Anesthesist a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 May 2011; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Ann De Cleene Anesthesist make in 2025?

Dr. Ann De Cleene Anesthesist posted a profit after taxes of € 84,971 in financial year 2025.

What is the revenue of Dr. Ann De Cleene Anesthesist?

As a small company, Dr. Ann De Cleene Anesthesist is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 142,403.

Dr. Ann De Cleene Anesthesist (Private Limited)

Dossier Dr. Ann De Cleene Anesthesist, printed on 18 September 2026 from databakkes.be/en/0836001725/dr-ann-de-cleene-anesthesist. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Ann De Cleene Anesthesist from Nazareth-De Pinte, company number BE0836001725, closed financial year 2025 with a result of € 84,971 after tax. For that financial year Dr. Ann De Cleene Anesthesist recorded a gross margin of € 142,403 and equity of € 305,895. Compared with financial year 2024, the result moved from € 73,056 to € 84,971. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 31, 2026.

What it is worth Healthy

€ 305,895

▼ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 84,971

▲ 16% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 247,734

▲ 48% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 122,320 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 50,735

▼ 23% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 30,532

▼ 35% vs 2024

€ 17,183 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 537

▼ 84% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,124

▼ 40% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 117,973 Gross margin 2022: € 117,973 First fiscal year in the series	€ 200,857 Gross margin 2023: € 200,857 ▲ 70% vs 2022 (€ 117,973) Favourable step	€ 126,312 Gross margin 2024: € 126,312 ▼ 37% vs 2023 (€ 200,857) Unfavourable step	€ 142,403 Gross margin 2025: € 142,403 ▲ 13% vs 2024 (€ 126,312) Favourable step	▲ 13%
Profit after taxes	€ 72,602 Profit after taxes 2022: € 72,602 First fiscal year in the series	€ 133,528 Profit after taxes 2023: € 133,528 ▲ 84% vs 2022 (€ 72,602) Favourable step	€ 73,056 Profit after taxes 2024: € 73,056 ▼ 45% vs 2023 (€ 133,528) Unfavourable step	€ 84,971 Profit after taxes 2025: € 84,971 ▲ 16% vs 2024 (€ 73,056) Favourable step	▲ 16%
Equity	€ 276,661 Equity 2022: € 276,661 First fiscal year in the series	€ 341,189 Equity 2023: € 341,189 ▲ 23% vs 2022 (€ 276,661) Favourable step	€ 343,245 Equity 2024: € 343,245 ▲ 1% vs 2023 (€ 341,189) Favourable step	€ 305,895 Equity 2025: € 305,895 ▼ 11% vs 2024 (€ 343,245) Unfavourable step	▼ 11%
Total debts	€ 35,006 Total debts 2022: € 35,006 First fiscal year in the series	€ 117,609 Total debts 2023: € 117,609 ▲ 236% vs 2022 (€ 35,006) Unfavourable step	€ 59,628 Total debts 2024: € 59,628 ▼ 49% vs 2023 (€ 117,609) Favourable step	€ 159,461 Total debts 2025: € 159,461 ▲ 167% vs 2024 (€ 59,628) Unfavourable step	▲ 167%
Cash	€ 165,597 Cash 2022: € 165,597 First fiscal year in the series	€ 220,611 Cash 2023: € 220,611 ▲ 33% vs 2022 (€ 165,597) Favourable step	€ 167,382 Cash 2024: € 167,382 ▼ 24% vs 2023 (€ 220,611) Unfavourable step	€ 247,734 Cash 2025: € 247,734 ▲ 48% vs 2024 (€ 167,382) Favourable step	▲ 48%
Retained profit	€ 264,261 Retained profit 2022: € 264,261 First fiscal year in the series	€ 328,789 Retained profit 2023: € 328,789 ▲ 24% vs 2022 (€ 264,261) Favourable step	€ 330,845 Retained profit 2024: € 330,845 ▲ 1% vs 2023 (€ 328,789) Favourable step	€ 293,495 Retained profit 2025: € 293,495 ▼ 11% vs 2024 (€ 330,845) Unfavourable step	▼ 11%
Dividend	€ 129,000 Dividend 2022: € 129,000 First fiscal year in the series	€ 69,000 Dividend 2023: € 69,000 ▼ 47% vs 2022 (€ 129,000) Unchanged	€ 71,000 Dividend 2024: € 71,000 ▲ 3% vs 2023 (€ 69,000) Unchanged	€ 122,320 Dividend 2025: € 122,320 ▲ 72% vs 2024 (€ 71,000) Unchanged	▲ 72%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 62,882 Bank debt 2023: € 62,882 Unchanged (€ 0) Unfavourable step	€ 47,036 Bank debt 2024: € 47,036 ▼ 25% vs 2023 (€ 62,882) Favourable step	€ 30,532 Bank debt 2025: € 30,532 ▼ 35% vs 2024 (€ 47,036) Favourable step	▼ 35%
Balance sheet total	€ 311,666 Balance sheet total 2022: € 311,666 First fiscal year in the series	€ 458,798 Balance sheet total 2023: € 458,798 ▲ 47% vs 2022 (€ 311,666) Unchanged	€ 402,873 Balance sheet total 2024: € 402,873 ▼ 12% vs 2023 (€ 458,798) Unchanged	€ 465,356 Balance sheet total 2025: € 465,356 ▲ 16% vs 2024 (€ 402,873) Unchanged	▲ 16%

Key figures of Dr. Ann De Cleene Anesthesist, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to Dr. Ann De Cleene Anesthesist?

What happened at Dr. Ann De Cleene Anesthesist in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 31, 2026 New annual accounts for financial year 2025: profit of € 84,971 (▲ 16% vs 2024). Source: NBB ↗
May 10, 2011 New establishment in Nazareth-De Pinte. KBO
May 2, 2011 Start of the company according to the CBE. KBO

In short

From € 72,602 profit in 2022 to € 84,971 profit in 2025.

Paid € 152,780 in corporate taxes since 2022.

Best year ever: 2023, with € 133,528 profit.

Paid out € 391,320 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Ann De Cleene Anesthesist? We notify you, reason included.

Follow Dr. Ann De Cleene Anesthesist

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Ann De Cleene

Dr. Ann De Cleene Anesthesist

Behind Dr. Ann De Cleene Anesthesist is Ann De Cleene.

See the full network in the app

Directors

According to the 2025 annual accounts

Ann De Cleene

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Pruimenbosstraat 13

9840 Nazareth-De Pinte

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0836.001.725
VAT number: BE 0836.001.725
Registered office: Pruimenbosstraat 13, 9840 Nazareth-De Pinte
Names & denominations: Dr. Ann De Cleene Anesthesist
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 2 May 2011
Peppol: Active · Active since 8 Jan 2026

View on CBE Public ↗ Annual accounts (NBB) ↗